SCHEMBL7206360

SCHEMBL7206360

CC(C)c1cc(C(C)C)c(C(=O)Cc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 2/20 0.51
FABP4 P15090 2/20 0.51
SOAT2 O75908 1/20 0.50
MYC P01106 1/20 0.50
SOAT1 P35610 1/20 0.50
MAP2K3 P46734 1/20 0.50
GABRA1 P14867 3/20 0.46
GABRG2 P18507 2/20 0.46
GABRB3 P28472 2/20 0.46
LPAR1 Q92633 2/20 0.41
FABP5 Q01469 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
GABRB2 P47870 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
LMNA P02545 2/20 0.37
CYP3A4 P08684 2/20 0.37
HPGD P15428 2/20 0.37
FAAH O00519 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207662 0.90 FABP4 (0.58) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL6940834 0.83 FABP3 (0.44) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL27898710 0.75 FABP3 (0.62) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL2380508 0.74 FABP4 (0.60) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL7207657 0.74 FABP3 (0.44) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL8136318 0.73 GABRA1 (0.57) SOAT2MYCSOAT1MAP2K3GABRA1
SCHEMBL4327412 0.73 FABP3 (0.58) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL7206347 0.72 GABRA1 (0.43) SOAT2MYCSOAT1MAP2K3GABRA1
SCHEMBL5456119 0.72 SOAT2 (0.67) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL2817756 0.72 GABRA1 (0.55) SOAT2MYCSOAT1MAP2K3GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed